NASDAQ:TLSA Tiziana Life Sciences 9/18/2026 Earnings Report $0.95 +0.18 (+23.36%) Closing price 04:00 PM EasternExtended Trading$0.93 -0.02 (-2.11%) As of 05:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Tiziana Life Sciences EPS ResultsActual EPSN/AConsensus EPS -$0.08Beat/MissN/AOne Year Ago EPSN/ATiziana Life Sciences Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/ATiziana Life Sciences Announcement DetailsQuarterDate9/18/2026TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile Tiziana Life Sciences Earnings HeadlinesTiziana Signs MOU With KAIMRC To Advance Foralumab MS Trials; Stock Up4 hours ago | rttnews.comTiziana Life Sciences partners with Saudi institutions on MS combination therapy trial4 hours ago | proactiveinvestors.comYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.September 17 at 1:00 AM | Profits Run (Ad)Tiziana Life Sciences Announces Signing of MOU with King Abdullah International Medical Research CenterSeptember 17 at 7:48 AM | markets.businessinsider.comTiziana Life Sciences consensus price target decreased by 11.11% to $8.16September 15 at 8:56 AM | msn.comTiziana Life Sciences (TLSA) to Announce Quarterly Earnings on FridaySeptember 11, 2026 | americanbankingnews.comSee More Tiziana Life Sciences Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Tiziana Life Sciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tiziana Life Sciences and other key companies, straight to your email. Email Address About Tiziana Life SciencesTiziana Life Sciences (NASDAQ:TLSA). (NASDAQ: TLSA) is a clinical-stage biotechnology company developing therapeutics for neuroinflammatory and autoimmune diseases. The company’s lead product candidate is foralumab, a fully human monoclonal antibody that targets the CD3 receptor on T cells and is being developed in an intranasal formulation designed to modulate immune activity. Tiziana has evaluated foralumab in clinical research involving non-active secondary progressive multiple sclerosis and has also investigated its potential in conditions involving neuroinflammation, including Alzheimer’s disease. The company’s development programs are focused on using immune modulation to address diseases affecting the central nervous system, with clinical and research activities conducted through collaborations and trials in relevant international markets. Tiziana Life Sciences was established as a biotechnology company focused on developing antibody-based treatments. Its scientific leadership includes founder and Chief Scientific Officer Kunwar Shailubhai, Ph.D., whose work has been associated with the company’s antibody development platform and foralumab program.View Tiziana Life Sciences ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Aeluma’s Selloff Could Be Setting Up Its Next Big MoveCoreWeave’s Vera Rubin Lead Comes Down to Speed, Power, and ScaleMicron’s New 512GB Memory Module Deepens Its AI Infrastructure AdvantageHoliday Shopping Is Almost Here—And Target May Be Ready to Win BigCan ServisFirst Keep Delivering?Banc of California Bets on Short-Term Pain3 Luxury Consumer Brands to Watch in a Beaten-Down Sector Upcoming Earnings Cintas (9/23/2026)Costco Wholesale (9/24/2026)Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/8/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
